Who owns the RED CELL THERAPEUTICS trademark?

The RED CELL THERAPEUTICS trademark is owned by Rubius Therapeutics, Inc..

What class is the RED CELL THERAPEUTICS trademark registered in?

The RED CELL THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for RED CELL THERAPEUTICS?

The USPTO serial number for RED CELL THERAPEUTICS is 87287791.

What is the registration number for RED CELL THERAPEUTICS?

RED CELL THERAPEUTICS is registered under USPTO registration number 6035628.

RED

USPTO Trademark Record

REGISTERED

RED CELL THERAPEUTICS

SN 87287791·Reg 6035628·Filed Jan 03, 2017

Owner Rubius Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

RED CELL THERAPEUTICS (Serial No. 87287791), Registration No. 6035628, is a registered US trademark filed on Jan 03, 2017 by Rubius Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

renewal grace 6y period: October 14, 202616 days remaining

Mark Intelligence

RED CELL THERAPEUTICS (Reg. #6035628) is a registered US trademark that has been protecting its owner, Rubius Therapeutics, Inc., since 2017. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

Jan 03, 2017

SERIAL

87287791

REG#

6035628

REGISTERED

Apr 14, 2020

Owner

Applicant

Rubius Therapeutics, Inc.

Entity

Corporation

State

Address

399 Binney Street, Cambridge, MA, 02139

Country

Attorney

NameChristina M. Licursi, Esq.

Law firm

CHRISTINA M. LICURSI, ESQ. WOLF GREENFIELD & SACKS, P.C.

Docket

R076520005US

Address

600 ATLANTIC AVENUE, BOSTON, MA 02210-2206, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJan 03, 2017

Serial Number87287791

Registration No.6035628

Registration DateApr 14, 2020

Status DateApr 14, 2020

Mark TypeStandard characters

Attorney DocketR076520005US

Status DescriptionLive and registered

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Dec 09, 2015

First use in commerce: Dec 09, 2015

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

44 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Apr 14, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-SUPPLEMENTAL REGISTER

Apr 14, 2020

REGISTERED-SUPPLEMENTAL REGISTER

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 10, 2020

LAW OFFICE PUBLICATION REVIEW COMPLETED

EXAMINER'S AMENDMENT ENTERED

Mar 05, 2020

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Mar 05, 2020

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Mar 05, 2020

EXAMINERS AMENDMENT -WRITTEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 05, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT E-MAILED

Mar 05, 2020

EXAMINERS AMENDMENT E-MAILED

SUBSEQUENT FINAL EMAILED

Aug 23, 2019

SUBSEQUENT FINAL EMAILED

SUBSEQUENT FINAL REFUSAL WRITTEN

Aug 23, 2019

SUBSEQUENT FINAL REFUSAL WRITTEN

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

Aug 23, 2019

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 03, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 02, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 02, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Feb 12, 2019

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 11, 2019

NOTIFICATION OF NON-FINAL ACTION E-MAILED

USE AMENDMENT ACCEPTED

Feb 11, 2019

USE AMENDMENT ACCEPTED

NON-FINAL ACTION E-MAILED

Feb 11, 2019

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Feb 11, 2019

NON-FINAL ACTION WRITTEN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Feb 06, 2019

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Feb 06, 2019

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

AMENDMENT TO USE PROCESSING COMPLETE

Jan 08, 2019

AMENDMENT TO USE PROCESSING COMPLETE

USE AMENDMENT FILED

Jan 08, 2019

USE AMENDMENT FILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 04, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 04, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS AMENDMENT OF USE RECEIVED

Jan 02, 2019

TEAS AMENDMENT OF USE RECEIVED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 02, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 02, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Jul 02, 2018

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Jul 02, 2018

NON-FINAL ACTION WRITTEN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

May 02, 2018

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

May 02, 2018

TEAS CHANGE OF OWNER ADDRESS RECEIVED

NOTIFICATION OF FINAL REFUSAL EMAILED

Jan 13, 2018

NOTIFICATION OF FINAL REFUSAL EMAILED

FINAL REFUSAL WRITTEN

Jan 13, 2018

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Jan 13, 2018

FINAL REFUSAL E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 25, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 25, 2017

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Oct 18, 2017

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 04, 2017

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Apr 04, 2017

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 04, 2017

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 04, 2017

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 28, 2017

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 12, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

RED CELL THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Rubius Therapeutics, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Christina M. Licursi, Esq.

Resources

Company